GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $200,000 | -41.2% | 4,541 | -46.9% | 0.01% | -57.1% |
| Q2 2021 | $340,000 | +11.5% | 8,549 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $305,000 | -22.8% | 8,549 | +1.6% | 0.01% | +100.0% |
| Q4 2019 | $395,000 | +10.0% | 8,411 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $359,000 | +7.2% | 8,411 | +0.4% | 0.01% | +20.0% |
| Q2 2019 | $335,000 | -4.3% | 8,380 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $350,000 | +9.7% | 8,380 | +0.4% | 0.01% | 0.0% |
| Q4 2018 | $319,000 | -3.9% | 8,345 | +0.9% | 0.01% | 0.0% |
| Q3 2018 | $332,000 | -0.3% | 8,273 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $333,000 | -69.5% | 8,273 | -70.4% | 0.01% | -66.7% |
| Q1 2018 | $1,091,000 | +10.2% | 27,916 | -0.0% | 0.02% | +7.1% |
| Q4 2017 | $990,000 | -10.3% | 27,917 | +2.7% | 0.01% | -12.5% |
| Q3 2017 | $1,104,000 | -3.3% | 27,193 | +2.6% | 0.02% | 0.0% |
| Q2 2017 | $1,142,000 | +6.6% | 26,495 | +4.3% | 0.02% | +14.3% |
| Q1 2017 | $1,071,000 | +5.7% | 25,392 | -3.5% | 0.01% | +7.7% |
| Q4 2016 | $1,013,000 | -7.1% | 26,315 | +4.1% | 0.01% | -7.1% |
| Q3 2016 | $1,090,000 | -2.8% | 25,284 | -2.2% | 0.01% | +7.7% |
| Q2 2016 | $1,121,000 | -46.1% | 25,857 | -49.6% | 0.01% | -43.5% |
| Q1 2016 | $2,081,000 | -0.8% | 51,331 | -1.2% | 0.02% | 0.0% |
| Q4 2015 | $2,097,000 | +6.0% | 51,973 | +1.0% | 0.02% | +21.1% |
| Q3 2015 | $1,978,000 | -40.8% | 51,451 | -35.8% | 0.02% | -32.1% |
| Q2 2015 | $3,339,000 | -13.4% | 80,157 | -4.1% | 0.03% | -3.4% |
| Q1 2015 | $3,857,000 | +8.4% | 83,578 | +0.4% | 0.03% | 0.0% |
| Q4 2014 | $3,557,000 | -7.3% | 83,233 | -0.3% | 0.03% | -23.7% |
| Q3 2014 | $3,837,000 | -14.1% | 83,462 | -0.1% | 0.04% | -32.1% |
| Q2 2014 | $4,467,000 | +0.2% | 83,528 | +0.1% | 0.06% | -16.4% |
| Q1 2014 | $4,459,000 | +0.1% | 83,452 | 0.0% | 0.07% | -36.8% |
| Q4 2013 | $4,456,000 | – | 83,452 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |